Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: A case-control study

Journal of Interferon and Cytokine Research

Volumn 31, Issue 2, 2011, Pages 259-264

  Bennermo, Marie ^a   Nordin, Margareta ^b   Lundman, Pia ^a   Boqvist, Susanna ^b   Held, Claes ^b   Samnegård, Ann ^a   Ericsson, Carl Göran ^a   Silveira, Angela ^b   Hamsten, Anders ^b   Nastase, Maria Mannila ^b   Tornvall, Per ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTERLEUKIN 6;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HEART INFARCTION; HELICOBACTER PYLORI; HEREDITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HYPERTENSION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ANTIBODIES; CASE-CONTROL STUDIES; ENVIRONMENT; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HERPES; HUMAN HERPESVIRUS 4;

EID: 79951830023     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0036     Document Type: Article

References (26)

1. Barton BE. 1996. The biological effects of interleukin 6. Med Res Rev 1:87-109. (Pubitemid 26034189)
2. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, Tornvall P. 2004. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem 50:2136-2140. (Pubitemid 39425852)
3. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A. 1999. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99:2079-2084. (Pubitemid 29196789)
4. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. 1996. Elevated levels of interleukin-6 in unstable angina. Circulation 94: 874-877. (Pubitemid 26292834)
5. Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G, Hafner G, Ossendorf M, Steinhagen K, Meyer J. 2001. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 103:2915-2921. (Pubitemid 32578128)
6. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. 2001. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21:1458-1463. (Pubitemid 34219808)
7. Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Posatti G, Andreotti F. 2001. Relation of the-174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88:1125-1128.
8. Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A, Thomas D, Raymond J, Bastard J, Drobinski G, Orfila J, Agut H, Thomas D. 2000. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 86:379-384. (Pubitemid 30628601)
9. De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. 2002. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 160:457-463. (Pubitemid 34159341)
10. Endler G, Marsik C, Joukhadar C, Marculescu R, Mayr F, Mannhalter C, Wagner OF, Jilma B. 2004. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 50:195-200. (Pubitemid 38125718)
11. Eriksson P, Deguchi H, Samnegard A, Lundman P, Boquist S, Tornvall P, Eriksson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A. 2004. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 24:551-557. (Pubitemid 38326152)
12. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J; AtheroGene Investigators. 2002. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21. (Pubitemid 34049136)
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. Effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376. (Pubitemid 28467565)
14. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L; AtheroGene Group. 2003. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92:515-521. (Pubitemid 37013401)
15. Grillner L. 1987. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests. J Virol Methods 17:133-139. (Pubitemid 17135073)
16. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. 2001. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or non-invasive strategy. JAMA 286:2107-2113. (Pubitemid 34041595)
17. Ljungman P, Bellander T, Nyberg F, Lampa E, Jacquemin B, Kolz M, Lanki T, Mitropoulos J, Müller M, Picciotto S, Pistelli R, Rückerl R, Koenig W, Peters A; AIRGENE Study Group. 2009. DNA variants, plasma levels and variability of interleukin- 6 in myocardial infarction survivors: results from the AIRGENE study. Thromb Res 124:57-64.
18. Paoletti R, Gotto AM Jr., Hajjar DP. 2004. Inflammation in atherosclerosis and implications for therapy. Circulation 109: III20-III26.
19. Ridker PM, Danesh J, Youngman L, Collins R, Stampfer MJ, Peto R, Hennekens CH. 2001. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 135:184-188. (Pubitemid 32738312)
20. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772. (Pubitemid 30213096)
21. Ross R. 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126.
22. Saleh N, Kovacs A, Tornvall P. 2009. Relevance of genetic polymorphisms in inflammatory response to percutaneous coronary intervention. Scand J Clin Lab Invest 69:736-740.
23. Saleh N, Svane B, Jensen J, Hansson L-O, Nordin M, Tornvall P. 2005. Stentimplantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 149:876-882. (Pubitemid 40718885)
24. Zhu J, Quyyumi AA, Muhlestein JB, Nieto FJ, Horne BD, Zalles- Ganley A, Anderson JL, Epstein SE. 2002. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 89:155-158. (Pubitemid 34132902)
25. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. 1999. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 34:1738-1743.
26. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE. 2000. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 85:140-146. (Pubitemid 30026092)